The study will test the hypothesis that young survivors who receive the tailored survivorship care plan will have improved estrogen deprivation symptoms, fertility concerns, contraception, and sexual function compared to those who do not receive the plan. Healthcare providers who receive the tailored plan will have improved preparedness on managing reproductive health issues in young survivors and more discussion of these issues with their patients, compared to providers who do not receive the plan.
The objective of the project is to generate and test the rhSCP intervention targeting young breast cancer survivors and their healthcare providers. The study aims include:
- To develop a prototype for the tailored rhSCP targeting symptoms of estrogen deprivation, fertility concerns, contraception, and sexual health in YBCS
- To pilot test the tailored rhSCP prototype with YBCS and HCPs, key stakeholders in managing reproductive health issues in survivorship
- To determine efficacy of the rhSCP in YBCS and HCPs through a randomized controlled clinical trial.
The purpose of this study was to test a reproductive health survivorship care plan developed specifically for young breast cancer survivors that addressed reproductive health concerns such as hot flashes, fertility, birth control, genetics, and sexual function. These are topics that are not addressed in most survivorship care plans. The researchers turned to the Army of Women (AOW) to enroll up to 150 volunteers from anywhere in the U.S. The Call to Action for this study was sent to AOW members on October 12, 2016. The researchers closed enrollment on May 16, 2017, after the AOW provided them with 251 women who were interested in enrolling in the study.